Strongbridge Biopharma (NASDAQ:SBBP)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - SBBP
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - SBBP
- Market Cap$207.780m
- SymbolNASDAQ:SBBP
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINIE00BYZ5XL97
Company Profile
Strongbridge Biopharma PLC is a biopharmaceutical company which focuses on the development, in-licensing, acquisition, and commercialization of various complementary products and product candidates that target rare diseases. The product portfolio of the group includes COR-003(levoketoconazole) and COR-005 (veldoreotide). COR-003 is a cortisol inhibitor which is used for the treatment of endogenous cushing's syndrome and COR-005 a novel somatostatin analog, which is used for the treatment of acromegaly. In addition, it is also developing BP-2002 (gene modified probiotic) which will be used for the treatment of Diabetes. Geographically, business activity of the firm is primarily functioned through the United States.Strongbridge Biopharma PLC is a biopharmaceutical company which focuses on the development, in-licensing, acquisition, and commercialization of various complementary products and product candidates that target rare diseases.
Latest SBBP news
Currently there for this company. Visit our news hub for other news .